Is your child currently experiencing CD and UC flare-ups? Local CD clinical research is testing a potential new medication to see if it may reduce swollen joints, blood in the stool, constant need to poop, malnutrition, and/or liver disease associated with CD and UC.
If you’re concerned about how CD and UC affects your child’s life, find out more about the CD clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

We are looking for young people 2 to 17 years of age to join a Crohn’s disease trial to help us discover more about treating CD. If you are looking for a potential new treatment option for CD or Crohn’s (including associated symptoms such as fever, reduced appetite, rectal pain, malnutrition and/or canker sores), consider one of our GI clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the GI clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Find out if your child qualifies.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local research is testing a potential new medication to see if it may reduce swollen joints, growth failure, bloody stool, weight loss, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for young people 2 to 17 years old to join a Crohn’s disease research study to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe ulcerative colitis (including associated symptoms such as chronic diarrhea, perianal fistula, rectal pain, malnutrition and/or joint pain), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited so act quickly.

Is your child currently experiencing moderately to severely active IBD flare-ups? Local clinical trial is testing a potential new medication to see if it may reduce diarrhea with pus, persistent diarrhea, rectal pain, frequent fevers, and/or eye pain associated with moderately to severely active IBD.
If you’re concerned about how moderately to severely active IBD affects your child’s life, find out more about the clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?

We are looking for young people 2 to 17 years old to join a CD research to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or moderate to severe UC (including associated symptoms such as long-term diarrhea, failure to thrive, diarrhea, frequent fevers and/or eye pain), consider one of our IBD clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Is your child eligible?

Is your child currently experiencing moderate to severe UC flare-ups? Local Crohn’s disease (CD) clinical trial is testing a potential new medication to see if it may reduce diarrhea, abdominal cramps, rectal pain, chronic fatigue, and/or liver disease associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the Crohn’s disease (CD) clinical trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people 2 to 17 years of age to join a Crohn’s disease medical research study to help us discover more about treating gastrointestinal disease. If you are looking for a potential new treatment option for gastrointestinal disease or moderate to severe ulcerative colitis (including associated symptoms such as chronic diarrhea, stomach pain, bloody stool, malnutrition and/or anemia), consider one of our UC studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the UC studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe UC flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce long-term diarrhea, weight loss, bloody stool, weight loss, and/or eye pain associated with moderate to severe UC.
If you’re concerned about how moderate to severe UC affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited, so please respond now.

We are looking for children and teens 2–17 years of age to join a Crohn’s disease (CD) clinical research to help us discover more about treating inflammatory bowel disease. If you are looking for a potential new treatment option for inflammatory bowel disease or Inflammatory bowel disease (including associated symptoms such as diarrhea with pus, blood in the stool, cramps, weight loss and/or liver disease), consider one of our IBD studies. All eligible participants will receive no-cost study-related care and study medication. Your children and teens 2–17 years of age may be eligible to take part.

Your child may be eligible to take part in the IBD studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.